Presentation is loading. Please wait.

Presentation is loading. Please wait.

Schematic diagram showing as yet unexplored pathophysiological mechanisms in pulmonary arterial hypertension (PAH). Schematic diagram showing as yet unexplored.

Similar presentations


Presentation on theme: "Schematic diagram showing as yet unexplored pathophysiological mechanisms in pulmonary arterial hypertension (PAH). Schematic diagram showing as yet unexplored."— Presentation transcript:

1 Schematic diagram showing as yet unexplored pathophysiological mechanisms in pulmonary arterial hypertension (PAH). Schematic diagram showing as yet unexplored pathophysiological mechanisms in pulmonary arterial hypertension (PAH). RV: right ventricular; ETRAs: endothelin receptor antagonists; PDE-5: phosphodiesterase-5; CRT: cardiac resynchronisation therapy; SNS: sympathetic nervous system; RAAS: renin–angiotensin–aldosterone system; ACEIs: angiotensin-converting enzyme inhibitors; ARBs: angiotension receptor blockers; MSNA: muscle sympathetic nervous activity; HRV: heart rate variability; βAR: cardiomyocyte β1-adrenergic receptor; AT1R: cardiomyocyte angiotensin type 1 receptor; Aldo ant: aldosterone antagonist; RHF: right heart failure; ICD: implantable cardioverter defibrillator. M. L. Handoko et al. Eur Respir Rev 2010;19:72-82 ©2010 by European Respiratory Society


Download ppt "Schematic diagram showing as yet unexplored pathophysiological mechanisms in pulmonary arterial hypertension (PAH). Schematic diagram showing as yet unexplored."

Similar presentations


Ads by Google